Register to our newsletter and get insights from our entrepreneurs and experts delivered to your inbox every month.
Purple Biotech Reports Biomarker Data from CM24 Phase 1 Dose Escalation Study
Thirteen high-growth companies join Scale Up Vaud in 2023
Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer
Life sciences entrepreneurs at Biopôle never stop innovating. Enter your e-mail and get monthly updates delivered to your inbox